| 000 | 01470 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515023937.0 | ||
| 264 | 0 | _c20061010 | |
| 008 | 200610s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1086/504089 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLanzafame, Massimiliano | |
| 245 | 0 | 0 |
_aTenofovir-associated kidney diseases and interactions between tenofovir and other antiretrovirals. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cJun 2006 |
||
| 300 |
_a1656-7; author reply 1658 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAcute Kidney Injury _xchemically induced |
| 650 | 0 | 4 |
_aAdenine _xadverse effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganophosphonates _xadverse effects |
| 650 | 0 | 4 | _aTenofovir |
| 700 | 1 | _aLattuada, Emanuela | |
| 700 | 1 | _aRapagna, Francesca | |
| 700 | 1 | _aGottardi, Martina | |
| 700 | 1 | _aVento, Sandro | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 42 _gno. 11 _gp. 1656-7; author reply 1658 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/504089 _zAvailable from publisher's website |
| 999 |
_c16254312 _d16254312 |
||